Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.273 EUR | -0.64% |
|
+4.24% | -30.64% |
26/06 | Valneva SE Appoints Daniele Guyot-Caparros as Board of Directors | CI |
24/06 | Valneva's Chikungunya Vaccine Receives Health Canada's Approval | MT |
Chart calendar Valneva
Upcoming events on Valneva
Past events on Valneva
26/06/2024 05:30 pm | Annual General Meeting |
25/06/2024 | Stifel European Healthcare Summit |
12/06/2024 | Portzamparc Conference |
10/06/2024 | Goldman Sachs Global Healthcare Conference |
06/06/2024 11:30 pm | Jefferies Global Healthcare Conference - Fireside Chat |
06/06/2024 | Oddo BHF Nextcap Forum |
03/06/2024 | BIO International Convention Conferene |
07/05/2024 06:30 pm | Q1 2024 Earnings Call |
07/05/2024 10:30 am | Q1 2024 Earnings Release |
16/04/2024 | Van Lanschot Kempen Life Sciences Conference |
01/04/2024 | World Vaccine Congress |
20/03/2024 07:30 pm | Q4 2023 Earnings Call |
20/03/2024 11:30 am | Q4 2023 Earnings Release |
04/03/2024 | TD Cowen Health Care Conference |
15/02/2024 11:30 am | Q4 2023 Sales and Revenue Release |
07/02/2024 09:00 pm | Guggenheim Healthcare Talks Biotechnology Conference |
15/01/2024 | Oddo BHF Forum |
08/01/2024 | JPMorgan Healthcare Conference |
20/12/2023 06:30 pm | Extraordinary Shareholders Meeting |
14/11/2023 08:00 pm | Jefferies London Healthcare Conference |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 126 124 1.84% | 110 121 -8.96% | 348 103 237.38% | 361 342 5.67% | 154 168 -8.63% | 190 |
EBITDA Million EUR | Released Forecast Spread | 7,80 10,6 -26.16% | -45,2 -42,9 -5.26% | -47,1 -31,6 -48.94% | -69,2 -30,3 -128.36% | -65,2 -65,1 -0.21% | 49,9 |
EBIT Million EUR | Released Forecast Spread | -0,81 1,73 -146.99% | -55,1 -52,7 -4.61% | -61,4 -63,7 3.55% | -113 -33,8 -235.21% | -82,1 -58,3 -40.89% | 27,5 |
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -0,87 -3,96 78.01% | -65,3 -64,1 -1.95% | -70,0 55,6 -225.97% | -145 -84,4 -71.58% | -98,6 -91,3 -7.99% | -0,91 |
Net income Million EUR | Released Forecast Spread | -1,70 -4,87 65.1% | -64,4 -62,7 -2.74% | -73,4 -64,3 -14.14% | -143 -85,4 -67.77% | -101 -90,8 -11.69% | 6,72 |
EPS EUR | Released Forecast Spread | -0,02 -0,05 56.1% | -0,71 -0,69 -3.5% | -0,75 -0,61 -22.95% | -1,24 -0,59 -110.17% | -0,73 -0,52 -41.42% | 0,11 |
Announcement Date | 27/02/20 | 25/02/21 | 03/02/22 | 23/03/23 | 21/03/24 | - |
Quarterly results
Fiscal Period | December | 2020 S1 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 47,9 72,5 -33.92% | 21,8 22,6 -3.57% | 71,4 21,4 232.96% | 93,2 45,3 105.69% | 157 116 34.81% | 111 90,0 23.73% | 33,5 30,4 10.29% | 40,2 33,1 21.5% | 38,1 41,4 -8.06% | 41,9 83,4 -49.74% | 32,8 66,6 -50.82% | 41,4 | 43,6 | 55,4 |
EBITDA Million EUR | Released Forecast Spread | -13,3 -48,7 72.69% | -123 -43,0 -185.35% | -5,20 | |||||||||||
EBIT Million EUR | Released Forecast Spread | -21,9 -9,20 -138.35% | -18,4 -69,6 73.56% | -129 -45,2 -185.02% | -147 -98,9 -48.8% | 93,3 36,2 158.09% | -56,4 34,9 -261.4% | -16,6 -21,5 22.8% | -20,3 -18,4 -9.98% | -22,2 -22,5 1.16% | -24,9 24,5 -201.85% | 68,2 78,0 -12.61% | -18,6 | -18,8 | -18,3 |
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -31,2 | -32,1 | -31,7 | |||||||||||
Net income Million EUR | Released Forecast Spread | -31,2 | -32,1 | -31,7 | |||||||||||
EPS EUR | Released Forecast Spread | -0,13 -0,14 7.14% | -0,12 -0,13 7.69% | -0,25 -0,12 -108.33% | -0,23 -0,14 -64.29% | 0,41 0,60 -31.67% | -0,08 | -0,11 | -0,10 | ||||||
Announcement Date | 04/08/20 | 05/05/22 | 11/08/22 | 11/08/22 | 10/11/22 | 23/03/23 | 04/05/23 | 21/09/23 | 09/11/23 | 21/03/24 | 07/05/24 | - | - | - |
15/07/2024 11:15 am | ADDLIFE AB: Q2 2024 Earnings Release |
22/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release |
24/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
24/07/2024 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
24/07/2024 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
24/07/2024 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
25/07/2024 | LONZA GROUP AG: Q2 2024 Earnings Release |
25/07/2024 10:30 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
26/07/2024 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
26/07/2024 10:30 am | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Valneva
07/06/2024 12:27 pm | POLARIS GROUP: May 2024 Sales and Revenue Release |
30/05/2024 01:31 am | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
23/05/2024 04:30 pm | CUREVAC N.V.: Q1 2024 Earnings Release |
22/05/2024 10:30 am | EVOTEC SE: Q1 2024 Earnings Release |
22/05/2024 02:44 am | ALVOTECH: Q1 2024 Earnings Release |
21/05/2024 04:30 pm | EXSCIENTIA PLC: Q1 2024 Earnings Release |
17/05/2024 11:30 am | BIOARCTIC AB: Q1 2024 Earnings Release |
16/05/2024 01:35 am | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
15/05/2024 04:30 pm | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
15/05/2024 | GNI GROUP LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- VLA Stock
- AYJ Stock
- Calendar Valneva